Lipids in the fight against the pandemic

In spring 2021, Evonik played a key role in accelerating the production of the Pfizer-BioNTech COVID-19 vaccine. Months ahead of schedule, Evonik supplied BioNTech with the lipids that were urgently needed for the mRNA-based vaccine.

This important contribution to the fight against the corornavirus pandemic was only possible thanks to outstanding cross-functional collaboration of more than 150 Evonik employees from Research & Development, Technical Service, Quality Assurance and Quality Control. In just three months, new processes and analytical methods were developed and production equipment for lipid production was set up in Hanau and Dossenheim. We achieved this all while maintaining the highest quality standards.

In the future, mRNA technology will also play an important role in the treatment of other diseases such as cancer and other infectious diseases. Evonik embraces the future of mRNA technology as a strong and reliable partner.